Published in Hum Mutat on March 01, 2007
New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol (2011) 3.97
Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med (2010) 2.44
Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet (2010) 2.27
The collagen family. Cold Spring Harb Perspect Biol (2011) 2.10
Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet (2009) 2.03
Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem (2008) 1.92
MatrixDB, the extracellular matrix interaction database. Nucleic Acids Res (2010) 1.79
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta. PLoS Genet (2009) 1.68
Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res (2009) 1.56
Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection. Mol Biol Cell (2009) 1.55
Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res (2011) 1.53
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet (2012) 1.43
Gibbon genome and the fast karyotype evolution of small apes. Nature (2014) 1.43
Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships. Hum Mol Genet (2008) 1.42
Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet (2013) 1.39
Osteogenesis Imperfecta: A Review with Clinical Examples. Mol Syndromol (2011) 1.38
ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet (2008) 1.37
New genes in bone development: what's new in osteogenesis imperfecta. J Clin Endocrinol Metab (2013) 1.29
A mouse model for human osteogenesis imperfecta type VI. J Bone Miner Res (2013) 1.27
Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum Mol Genet (2011) 1.23
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta. Nat Med (2014) 1.21
Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. J Biol Chem (2008) 1.21
Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag (2010) 1.21
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer (2013) 1.20
Integrins α2β1 and α11β1 regulate the survival of mesenchymal stem cells on collagen I. Cell Death Dis (2011) 1.19
Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr (2014) 1.12
Procollagen triple helix assembly: an unconventional chaperone-assisted folding paradigm. PLoS One (2007) 1.11
Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta (2009) 1.10
Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta. J Struct Biol (2010) 1.08
A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta. Genet Med (2012) 1.08
Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet (2009) 1.07
Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling. J Biol Chem (2012) 1.07
The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta. J Bone Miner Metab (2011) 1.06
Natural variation in four human collagen genes across an ethnically diverse population. Genomics (2008) 1.03
Caffey disease: new perspectives on old questions. Bone (2013) 1.02
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells (2012) 1.00
Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathies. Hum Mutat (2013) 0.99
Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet. PLoS One (2012) 0.98
Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet (2010) 0.97
Recombinant collagen studies link the severe conformational changes induced by osteogenesis imperfecta mutations to the disruption of a set of interchain salt bridges. J Biol Chem (2008) 0.96
Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J Bone Miner Res (2010) 0.96
NMR conformational and dynamic consequences of a gly to ser substitution in an osteogenesis imperfecta collagen model peptide. J Biol Chem (2009) 0.94
Structural biology: Modelling collagen diseases. Nature (2008) 0.94
Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). Bone (2008) 0.94
Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene. Am J Hum Genet (2010) 0.93
Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta. PLoS Genet (2014) 0.93
Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention. Circulation (2015) 0.93
Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos (2011) 0.92
Common interruptions in the repeating tripeptide sequence of non-fibrillar collagens: sequence analysis and structural studies on triple-helix peptide models. J Mol Biol (2007) 0.92
Rare bone diseases and their dental, oral, and craniofacial manifestations. J Dent Res (2014) 0.92
Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans. Orphanet J Rare Dis (2013) 0.91
Collagen XXVII organises the pericellular matrix in the growth plate. PLoS One (2011) 0.90
Sequence dependence of kinetics and morphology of collagen model peptide self-assembly into higher order structures. Protein Sci (2008) 0.90
Alternative splicing modifies the effect of mutations in COL11A1 and results in recessive type 2 Stickler syndrome with profound hearing loss. J Med Genet (2013) 0.90
Increased susceptibility to microdamage in Brtl/+ mouse model for osteogenesis imperfecta. Bone (2011) 0.89
A novel missense mutation of COL5A2 in a patient with Ehlers-Danlos syndrome. Hum Genome Var (2016) 0.89
DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol (2013) 0.89
Bacterial collagen-like proteins that form triple-helical structures. J Struct Biol (2014) 0.89
Chaperoning osteogenesis: new protein-folding disease paradigms. Trends Cell Biol (2010) 0.89
Effects of tissue hydration on nanoscale structural morphology and mechanics of individual Type I collagen fibrils in the Brtl mouse model of Osteogenesis Imperfecta. J Struct Biol (2012) 0.89
Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta. Bone (2013) 0.88
Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit (2014) 0.88
A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res (2014) 0.88
Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells. Mol Cell Proteomics (2012) 0.87
Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome. Bonekey Rep (2013) 0.87
Direct in vitro and in vivo evidence for interaction between Hsp47 protein and collagen triple helix. J Biol Chem (2012) 0.86
Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet (2015) 0.85
Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype. Orphanet J Rare Dis (2011) 0.85
Positive selection neighboring functionally essential sites and disease-implicated regions of mammalian reproductive proteins. BMC Evol Biol (2010) 0.85
Interruptions in the collagen repeating tripeptide pattern can promote supramolecular association. Protein Sci (2010) 0.85
Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos Int (2016) 0.85
Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis (2015) 0.85
Location of glycine mutations within a bacterial collagen protein affects degree of disruption of triple-helix folding and conformation. J Biol Chem (2010) 0.84
Osteogenesis imperfecta model peptides: incorporation of residues replacing Gly within a triple helix achieved by renucleation and local flexibility. Biophys J (2011) 0.84
Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model. Ann Biomed Eng (2013) 0.83
Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration. Med Sci Monit (2014) 0.82
Skeletal muscle weakness in osteogenesis imperfecta mice. Matrix Biol (2010) 0.82
Sequence environment of mutation affects stability and folding in collagen model peptides of osteogenesis imperfecta. Biopolymers (2011) 0.82
A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfecta. PLoS One (2012) 0.81
Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. J Clin Endocrinol Metab (2014) 0.81
Mineral and matrix changes in Brtl/+ teeth provide insights into mineralization mechanisms. Biomed Res Int (2013) 0.81
Osteogenesis imperfecta missense mutations in collagen: structural consequences of a glycine to alanine replacement at a highly charged site. Biochemistry (2011) 0.81
Skeletal dysplasias. Clin Perinatol (2015) 0.80
Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis. J Med Genet (2006) 0.80
Recent developments in osteogenesis imperfecta. F1000Res (2015) 0.80
Structural constraints on the evolution of the collagen fibril: convergence on a 1014-residue COL domain. Open Biol (2015) 0.79
Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta. J Bone Miner Res (2016) 0.79
A brilliant breakthrough in OI type V. Osteoporos Int (2013) 0.79
Folding delay and structural perturbations caused by type IV collagen natural interruptions and nearby Gly missense mutations. J Biol Chem (2011) 0.79
IFITM5 mutations and osteogenesis imperfecta. J Bone Miner Metab (2015) 0.79
Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations. Matrix Biol (2016) 0.79
Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling. Connect Tissue Res (2014) 0.78
Allele dependent silencing of COL1A2 using small interfering RNAs. Int J Med Sci (2008) 0.78
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin. Sci Rep (2016) 0.78
Novel PAX9 and COL1A2 missense mutations causing tooth agenesis and OI/DGI without skeletal abnormalities. PLoS One (2012) 0.78
Molecular dynamics simulations of the full triple helical region of collagen type I provide an atomic scale view of the protein's regional heterogeneity. Pac Symp Biocomput (2011) 0.78
Dynamic Water-Mediated Hydrogen Bonding in a Collagen Model Peptide. Biochemistry (2015) 0.78
Genetic heterogeneity in osteogenesis imperfecta. J Med Genet (1979) 12.51
Nomenclature for the description of human sequence variations. Hum Genet (2001) 7.90
Osteogenesis imperfecta. Lancet (2004) 5.88
Heritable diseases of collagen. N Engl J Med (1984) 4.39
The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell (1997) 4.11
Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol (1998) 3.78
Proteoglycan-fibrillar collagen interactions. Biochem J (1988) 3.76
Collagen family of proteins. FASEB J (1991) 3.73
Procollagen trafficking, processing and fibrillogenesis. J Cell Sci (2005) 3.54
Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27
An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell (1997) 2.89
Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem (2001) 2.88
Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J (1991) 2.86
Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature (1983) 2.73
Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem (1999) 2.38
The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Annu Rev Biophys Biophys Chem (1991) 2.33
Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet (1991) 2.26
The Human Collagen Mutation Database 1998. Nucleic Acids Res (1998) 2.17
Prediction of collagen stability from amino acid sequence. J Biol Chem (2005) 2.11
The human type I collagen mutation database. Nucleic Acids Res (1997) 2.02
Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem (1998) 1.94
Standardizing mutation nomenclature: why bother? Hum Mutat (2003) 1.80
Localization of the binding site for cell attachment in the alpha1(I) chain of collagen. J Biol Chem (1978) 1.79
Localization of the cell attachment region in types I and II collagens. Biochem Biophys Res Commun (1976) 1.68
Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet (2004) 1.63
Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet (1996) 1.59
Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. Am J Med Genet (1989) 1.56
Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. J Biol Chem (2000) 1.54
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet (1994) 1.51
Analysis of CpG suppression in methylated and nonmethylated species. Proc Natl Acad Sci U S A (1992) 1.46
Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet (1993) 1.45
Decorin binds near the C terminus of type I collagen. J Biol Chem (2000) 1.40
cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci U S A (1997) 1.39
Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing. J Biol Chem (2005) 1.37
Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly. J Biol Chem (2003) 1.36
Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet (1992) 1.35
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases. J Biol Chem (2000) 1.35
Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem (1996) 1.34
The staining pattern of collagen fibrils. I. An analysis of electron micrographs. Connect Tissue Res (1974) 1.32
Inhibition of the self-assembly of collagen I into fibrils with synthetic peptides. Demonstration that assembly is driven by specific binding sites on the monomers. J Biol Chem (1998) 1.31
Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat (2004) 1.31
Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser (1979) 1.25
Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J Cell Biol (1993) 1.23
Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res A (2004) 1.20
Analysis of cytoplasmic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta. Methods Enzymol (1987) 1.16
Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation. Proc Natl Acad Sci U S A (1998) 1.12
Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet (2006) 1.12
Type I collagen-phosphophoryn interactions: specificity of the monomer-monomer binding. J Struct Biol (1998) 1.11
Proteoglycan: collagen interactions in connective tissues. Ultrastructural, biochemical, functional and evolutionary aspects. Int J Biol Macromol (1991) 1.09
Mapping the heparin-binding sites on type I collagen monomers and fibrils. J Cell Biol (1994) 1.08
Structural requirements for fibromodulin binding to collagen and the control of type I collagen fibrillogenesis--critical roles for disulphide bonding and the C-terminal region. Eur J Biochem (1998) 1.05
Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype. J Biol Chem (1993) 1.04
Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. J Clin Invest (1996) 1.04
Sequence specific thermal stability of the collagen triple helix. Int J Biol Macromol (1991) 1.03
The molecular genetics of collagen. Bioessays (1985) 0.99
Direct binding and activation of receptor tyrosine kinases by collagen. Cell (1997) 0.98
Peptide sequences in glutaraldehyde-linked proteodermatan sulphate: collagen fragments from rat tail tendon locate the proteoglycan binding sites. Biochem Soc Trans (1997) 0.93
Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites. J Biol Chem (1992) 0.92
Osteogenesis imperfecta: prospects for molecular therapeutics. Mol Genet Metab (2000) 0.92
Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies. J Bone Miner Res (1993) 0.91
Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. J Biol Chem (1993) 0.87
Induction of endothelial cell activation by a triple helical alpha2beta integrin ligand, derived from type I collagen alpha1(I)496-507. J Biol Chem (2003) 0.87
Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis. J Biol Chem (1989) 0.87
Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains. Matrix Biol (2000) 0.86
Glycation changes the charge distribution of type I collagen fibrils. Glycoconj J (1998) 0.81
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol (2007) 16.15
Neighborhood-based differences in physical activity: an environment scale evaluation. Am J Public Health (2003) 9.87
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet (2005) 9.62
Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med (2006) 9.50
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (2013) 5.93
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Osteogenesis imperfecta. Lancet (2004) 5.88
Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol (2010) 5.00
Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells (2002) 4.62
Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal Biochem (2002) 4.54
What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) (2006) 4.48
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet (2003) 4.44
Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A (2011) 4.27
An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem (2004) 4.12
CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell (2006) 4.10
Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet (2004) 4.09
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol (2011) 3.97
Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet (2007) 3.84
Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin. Nat Genet (2005) 3.55
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A (2006) 3.48
Sarcoma derived from cultured mesenchymal stem cells. Stem Cells (2006) 3.40
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36
In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A (2002) 3.28
Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A (2006) 3.24
Respiratory morbidity in late preterm births. JAMA (2010) 3.11
RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res (2003) 3.06
Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med (2006) 2.97
Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet (2004) 2.94
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet (2006) 2.94
WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med (2013) 2.91
Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem (2001) 2.88
The natural history of the normal first stage of labor. Obstet Gynecol (2010) 2.85
Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol (2006) 2.76
Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A (2010) 2.74
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A (2008) 2.70
CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat (2008) 2.66
Contemporary patterns of spontaneous labor with normal neonatal outcomes. Obstet Gynecol (2010) 2.62
Rapid detection of VHL exon deletions using real-time quantitative PCR. Lab Invest (2005) 2.61
Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A (2003) 2.59
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2008) 2.57
Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res (2002) 2.56
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol (2008) 2.51
Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med (2010) 2.44
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet (2012) 2.44
Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet (2010) 2.39
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther (2004) 2.35
Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun (2007) 2.35
Mutations in WNT1 are a cause of osteogenesis imperfecta. J Med Genet (2013) 2.32
Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J Med Genet (2007) 2.32
Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet (2010) 2.27
Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A (2005) 2.26
Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet (2008) 2.24
Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A (2006) 2.23
Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22
Locus Reference Genomic: reference sequences for the reporting of clinically relevant sequence variants. Nucleic Acids Res (2013) 2.18
Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood (2003) 2.13
RTPrimerDB: the real-time PCR primer and probe database, major update 2006. Nucleic Acids Res (2006) 2.11
Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat (2003) 2.10
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem (2003) 2.09
Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A (2004) 2.09
Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. J Natl Cancer Inst (2009) 2.09
Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet (2002) 2.07
Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One (2007) 2.06
Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr (2010) 2.06
Usefulness of bicuspid aortic valve phenotype to predict elastic properties of the ascending aorta. Am J Cardiol (2007) 2.05
Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells (2007) 2.05
Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet (2009) 2.02
Muscle mass, muscle strength, functional performance, and physical impairment in women with the hypermobility type of Ehlers-Danlos syndrome. Arthritis Care Res (Hoboken) (2012) 2.01
Compound heterozygous mutations of the TNXB gene cause primary myopathy. Neuromuscul Disord (2013) 2.01
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2008) 1.98
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab (2011) 1.98
Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol (2012) 1.98
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol (2010) 1.97
Netrin-1 and semaphorin 3A promote or inhibit cortical axon branching, respectively, by reorganization of the cytoskeleton. J Neurosci (2004) 1.97
Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells (2011) 1.96
Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol (2008) 1.95
Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res (2003) 1.94
Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med (2010) 1.94